Carisma Therapeutics, Inc. - Common Stock (CARM)

Stay up-to-date with the latest market trends one hour before the close of the markets on Tuesday. Explore the top gainers and losers during today's session in our detailed report.

Curious to know what's happening on the US markets in the middle of the day on Tuesday? Join us as we explore the top gainers and losers in today's session.

Investors and traders are closely monitoring the gap up and gap down stocks in today's session on Tuesday. Let's explore the market movements and identify the stocks with significant gaps.

Wondering what's happening in today's after-hours session? Stay tuned for the latest updates on stock movements.

CARM stock results show that CARISMA Therapeutics beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024.

Carisma Therapeutics Inc. (NASDAQ: CARM) shares are trading higher on Friday following the company's announcement of a significant development in its collaboration with Moderna.

Pre-market stock movers are a hot topic on Friday and we're breaking down all of the latest news sending shares higher and lower!

CARM stock results show that CARISMA Therapeutics missed analyst estimates for earnings per share and missed on revenue for the first quarter of 2024.

CARM stock results show that CARISMA Therapeutics beat analyst estimates for earnings per share and beat on revenue for the fourth quarter of 2023.

If you can handle the stomach-churning volatility and know when to call it quits, these top stocks under $5 could be intriguing.

Gainers CytoMed Therapeutics Limited (NASDAQ: GDTC) shares climbed 129.5% to $8.01 after gaining 9% on Monday.

U.S. stocks traded mixed, with the Dow Jones dropping around 50 points on Thursday. Here are some big stocks recording gains in today’s session.

Gainers Mobiquity Technologies, Inc. (NASDAQ: MOBQ) shares gained 124% to $0.3325. Mobiquity Technologies launched ElecAlytics, an AI-Powered analytics suite added to its ElecTech platform for political campaigns.